Piramal Pharma Solutions

Lexington, KY · Riverview, MI · Ahmedabad, IN
Find alternatives to Piramal Pharma Solutions for Biologics →
Biologics ADC Small Molecule API High-Potency APIs Oral Solid Dose
Program data pending ClinicalTrials.gov matching · Last scored 2026-11-12
87.0
Signal Score
✓ FDA Inspections (7) ○ Clinical Trials ○ SEC Filings ✓ Press (20) ✓ EMA GMP (1) ✓ MHRA GMP (14) ✓ HC GMP (23)

Quick Facts: Piramal Pharma Solutions

Signal Score
87.0/100 (as of 2026-11-12)
Quality Compliance
96.1/100 — Clean MHRA record: 14 compliant GMP certificates (no deductions)
Headquarters
Lexington, KY · Riverview, MI · Ahmedabad, IN
Modalities
Biologics, ADC, Small Molecule API, High-Potency APIs, Oral Solid Dose
Active Programs
No ClinicalTrials.gov matches confirmed — 2 partnership signals in press (announcements, not verified)
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Piramal Pharma Solutions

Indian pharma CDMO with US manufacturing.

Signal Score & Pillar Breakdown

Quality Compliance 96.1
Clean MHRA record: 14 compliant GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP, MHRA GMDP
Clean MHRA record: 14 compliant GMP certificates (no deductions)
FDA Inspections7 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2026-02-13)
EMA GMP Certificates1 on record
MHRA GMP Certificates14 on record
Most Recent HC OutcomeCompliant · 2026-02-09
HC Attribution23 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Clean MHRA record: 14 compliant GMP certificates (no deductions)
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 2 partnership announcements found in press monitoring.
Programs — no verified data
Sponsors— no verified data
ModalitiesBiologics, ADC, Small Molecule API, High-Potency APIs, Oral Solid Dose
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 83.0
Publicly traded — financial transparency
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Publicly traded — financial transparency
Capacity 75.0
Multi-site operations (8 manufacturing sites)
Broad modality coverage (5 modalities)
Sites: Lexington, KY, Riverview, MI, Ahmedabad, India, Morpeth, United Kingdom, Grangemouth, United Kingdom, Aurora, Canada, Digwal (Kohir), India, Turbhe (Navi Mumbai), India
Source: company profiles (manufacturing sites, modality breadth)
8 manufacturing sites
Press Signals20 articles (not scored)
Multi-site operations (8 manufacturing sites)
Broad modality coverage (5 modalities)

Piramal Pharma Solutions FDA Inspection History

2026-02
2025-12
2025-05
2025-02
2023-05
2023-03
2023-01
NAI VAI OAI
Date Site Type 483 citations posted Classification
2026-02-13
Piramal Pharma Limited
Kohir Mandal Facility-linked
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
2025-12-10
Piramal Pharma Solutions Inc.
Lexington, Kentucky Facility-linked
Drug Quality Assurance Yes Voluntary Action Indicated (VAI)
2025-05-30
Piramal Healthcare (Canada) Ltd.
Aurora Facility-linked
Drug Quality Assurance Not posted No Action Indicated (NAI)
2025-02-17
Piramal Pharma Limited
Navi Mumbai Facility-linked
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
2023-05-19
Piramal Pharma Limited
Pithampur Company-level
Drug Quality Assurance Not posted No Action Indicated (NAI)
2023-03-31
Piramal Pharma Limited
Kohir Mandal, Sangareddy District Facility-linked
Drug Quality Assurance Not posted No Action Indicated (NAI)
2023-01-10
Piramal Pharma Solutions Inc.
Lexington, Kentucky Facility-linked
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Nov 21, 2026

Piramal Pharma Solutions FDA 483 Findings 4 observations · 2025-12-10 → 2025-12-10 ?

By subsystem

  • Documentation & Records 2 (50.0%)
  • Data Integrity 1 (25.0%)
  • CAPA 1 (25.0%)

By severity

  • 5 — Critical: 1
  • 3 — Moderate: 1
  • 2 — Minor: 2
  • Repeat observations: 0

Most severe findings

  • Critical (5) Data Integrity 2025-12-10 21 CFR 211.68(b)
    Computer control of master formula records

    "Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel."

  • Moderate (3) CAPA 2025-12-10 21 CFR 211.192
    Investigations of discrepancies, failures

    "There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed."

  • Minor (2) Documentation & Records 2025-12-10 21 CFR 211.100(a)
    Absence of Written Procedures

    "Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess."

Piramal Pharma Solutions EMA GMP Compliance 1 certificates

2025-11
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
NL/H 25/2059654 Piramal Pharma Solutions (Dutch) B.V. Netherlands 2025-11-27 COMPLIANT
Source: EMA EudraGMDP · Retrieved Nov 21, 2026

Piramal Pharma Solutions MHRA GMP Compliance 14 certificates

2025-09
2025-09
2025-09
2025-09
2025-02
2025-02
2024-12
2024-12
2024-12
2024-12
2024-12
2024-02
2019-05
2019-05
Compliant Non-Compliant
Certificate Site City / Postcode Inspection Date Status
UK API 29595 Insp GMP/IMP 29595/10933-0018 [H] PIRAMAL HEALTHCARE UK LIMITED GRANGEMOUTH FK3 8XG 2025-09-02 COMPLIANT
UK API 29595 Insp GMP/IMP 29595/10933-0018 [V] PIRAMAL HEALTHCARE UK LIMITED GRANGEMOUTH FK3 8XG 2025-09-02 COMPLIANT
UK MIA 29595 Insp GMP/IMP 29595/10933-0018[H] PIRAMAL HEALTHCARE UK LIMITED GRANGEMOUTH FK3 8XG 2025-09-02 COMPLIANT
UK MIA(IMP) 29595 Insp GMP/IMP 29595/10933-0018[I] PIRAMAL HEALTHCARE UK LIMITED GRANGEMOUTH FK3 8XG 2025-09-02 COMPLIANT
UK GMP 18772 Insp GMP 18772/301330-0010 [H] PIRAMAL PHARMA LIMITED IN-502 321 2025-02-05 COMPLIANT
UK GMP 18772 Insp GMP 18772/301330-0010 [V] PIRAMAL PHARMA LIMITED IN-502 321 2025-02-05 COMPLIANT
UK API 29595 Insp GMP/GDP/IMP 29595/18244-0044 PIRAMAL HEALTHCARE UK LIMITED MORPETH NE61 3YA 2024-12-23 COMPLIANT
UK MIA(IMP) 29595 Insp GMP/GDP/IMP 29595/18244-0044[I] PIRAMAL HEALTHCARE UK LIMITED MORPETH NE61 3YA 2024-12-23 COMPLIANT
UK MIA 29595 Insp GMP/GDP/IMP 29595/18244-0044[H] PIRAMAL HEALTHCARE UK LIMITED MORPETH NE61 3YA 2024-12-23 COMPLIANT
UK API 29595 Insp GMP 29595/18244-0047 [H] PIRAMAL HEALTHCARE UK LIMITED MORPETH NE61 3YA 2024-12-23 COMPLIANT
UK API 29595 Insp GMP 29595/18244-0047 [V] PIRAMAL HEALTHCARE UK LIMITED MORPETH NE61 3YA 2024-12-23 COMPLIANT
UK MIA 29595 Insp GMP 29595/36189300-0002[H] PIRAMAL HEALTHCARE UK LIMITED GRANGEMOUTH FK3 8ZF 2024-02-06 COMPLIANT
UK GMP 54023 Insp GMP 54023/301330-0009 [H] PIRAMAL PHARMA LIMITED IN-502 321 2019-05-13 COMPLIANT
UK GMP 54023 Insp GMP 54023/301330-0009 [V] PIRAMAL PHARMA LIMITED IN-502 321 2019-05-13 COMPLIANT
Source: MHRA GMDP Database · Retrieved Nov 21, 2026

Japan-accredited overseas site (PMDA)

sterile, biologics, general (non-sterile) · 6 sites

  • Aurora, Canada · Piramal Healthcare (Canada) Limited — general (non-sterile) · valid to Sep 9, 2027
  • Navi Mumbai, India · Piramal Pharma Limited — general (non-sterile) · valid to Jul 17, 2029
  • Sangareddy, India · Piramal Pharma Limited — general (non-sterile) · valid to Jul 5, 2027
  • Grangemouth, United Kingdom · Piramal Healthcare UK Limited — biologics · valid to May 21, 2028
  • Morpeth, United Kingdom · Piramal Healthcare UK Limited — general (non-sterile) · valid to Dec 18, 2026 renewal due
  • Lexington, United States · Piramal Pharma Solutions Inc. — sterile · valid to Nov 10, 2029

PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No count for this company yet. The careers board we can read covers more than this business (97 postings on Nov 20, 2026), and we can't yet tell which of those roles belong to it. Why: the group's board only shows its ~100 newest postings across all units, so we can't separate this business's roles. We'd rather show no number than one that isn't really this company's.
Source: piramalpharma.wd102.myworkdayjobs.com · Checked Nov 20, 2026

Company Signals 20 articles

Company announcements, not verified evidence. They do not change any score.
financial 2026-10-28
Piramal Pharma Returns to Profit in Q2 FY27 as CDMO Revenue Jumps 36%, Raises FY27 Outlook - eHealth Magazine
Piramal Pharma Returns to Profit in Q2 FY27 as CDMO Revenue Jumps 36%, Raises FY27 Outlook  eHealth Magazine
facility_expansion 2026-10-19
Piramal Pharma opens in-house sterility testing suite in $85m US expansion - Cleanroom Technology
Piramal Pharma opens in-house sterility testing suite in $85m US expansion  Cleanroom Technology
regulatory 2026-10-07
Piramal Pharma Solutions launches new microbiology laboratory at Lexington sterile injectable facility - BioSpectrum India
Piramal Pharma Solutions launches new microbiology laboratory at Lexington sterile injectable facility  BioSpectrum India
general 2026-10-06
Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase next month - Manufacturing Chemist
Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase next month  Manufacturing Chemist
general 2026-10-06
/C O R R E C T I O N -- Piramal Pharma Solutions/ - PR Newswire Canada
/C O R R E C T I O N -- Piramal Pharma Solutions/  PR Newswire Canada
general 2026-10-06
Piramal Pharma receives Ontario investment for API site - Manufacturing Chemist
Piramal Pharma receives Ontario investment for API site  Manufacturing Chemist
facility_expansion 2026-10-06
Piramal Pharma Opens New Microbiology Lab at US Sterile Injectables Facility - Medical Dialogues
Piramal Pharma Opens New Microbiology Lab at US Sterile Injectables Facility  Medical Dialogues
general 2026-10-06
Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility - The Malaysian Reserve
Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility  The Malaysian Reserve
general 2026-10-02
Piramal Pharma Solutions to Invest USD 5.3 Mn in Canada Facility Upgrade With Ontario Support - Medical Dialogues
Piramal Pharma Solutions to Invest USD 5.3 Mn in Canada Facility Upgrade With Ontario Support  Medical Dialogues
general 2026-10-01
Ont. Government Invests $1.7M In Piramal Pharma Solutions' Aurora, Ont. Facility - Canadian Manufacturing
Ont. Government Invests $1.7M In Piramal Pharma Solutions' Aurora, Ont. Facility  Canadian Manufacturing
general 2026-10-01
Business News | Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month - LatestLY
Business News | Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month  LatestLY
general 2026-09-30
Ontario contributes $1.7 M investment to advance life sciences innovation at Piramal Pharma's Aurora facility - BioSpectrum Asia
Ontario contributes $1.7 M investment to advance life sciences innovation at Piramal Pharma's Aurora facility  BioSpectrum Asia
general 2026-09-30
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's... - BizzBuzz
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's...  BizzBuzz
general 2026-09-29
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility - StreetInsider
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility  StreetInsider
regulatory 2026-04-28
Piramal Pharma Solutions appoints Gregory Judge as Director to strengthen European business - Indian Pharma Post
Piramal Pharma Solutions appoints Gregory Judge as Director to strengthen European business  Indian Pharma Post
general 2026-04-18
Piramal, Ajinomoto team on ADC development and manufacturing - megaproject.com
Piramal, Ajinomoto team on ADC development and manufacturing  Marcus Theatres
general 2026-04-17
Piramal–Ajinomoto Partner for ADC Manufacturing - Voice of Healthcare
Piramal–Ajinomoto Partner for ADC Manufacturing  Voice of Healthcare
partnership 2026-04-16
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing - Big News Network.com
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing  Big News Network.com
partnership 2026-04-16
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and... - lokmattimes.com
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and...  lokmattimes.com
general 2026-04-16
Piramal, Aji Bio-Pharma Partner to Support ADC Development & Manufacturing - Contract Pharma
Piramal, Aji Bio-Pharma Partner to Support ADC Development & Manufacturing  Contract Pharma

Frequently Asked Questions About Piramal Pharma Solutions

How many FDA inspections does Piramal Pharma Solutions have on record?
CDMO Signal tracks 7 FDA inspections for Piramal Pharma Solutions, sourced from the FDA inspection database. See the full inspection history above.
Has Piramal Pharma Solutions received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Piramal Pharma Solutions.
Does Piramal Pharma Solutions hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 EMA and 14 MHRA GMP certificates for Piramal Pharma Solutions.
What is Piramal Pharma Solutions's CDMO Signal Score?
Piramal Pharma Solutions has a Signal Score of 87/100, based on quality, operations, financial stability, and capacity data.
Evaluating Piramal Pharma Solutions for a manufacturing program?
Use the free AI matchmaker to compare Piramal Pharma Solutions against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics CDMOs → ADC CDMOs →

Similar CDMOs

Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 90.1
Biologics, mRNA, Small Molecule API, Oral Solid Dose, High-Potency APIs, Sterile Fill-Finish
Lonza
Basel, Switzerland
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation, Small Molecule API, High-Potency APIs, Oral Solid Dose
AbbVie Contract Manufacturing
North Chicago, Illinois, United States
Small Molecule API, High-Potency APIs, Biologics, ADC / Bioconjugation, Sterile Fill-Finish, Lyophilization, Prefilled Syringes, Oral Solid Dose, Hot-Melt Extrusion, Oral Liquids, Topicals
NerPharMa
Nerviano (Milan), Italy
High-Potency APIs, Oncology Products, Small Molecule API, Sterile Injectables, Oral Solid Dose, Biologics
Cadila Pharmaceuticals (CDMO-CMO)
Ahmedabad, Gujarat, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Biologics

Compare Piramal Pharma Solutions with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Piramal Pharma Solutions
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.